Amgen’s new drug could be a blockbuster
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Semtech shares up after company reports income and revenue growth
Semtech Corp., a Camarillo semiconductor company specializing in Internet of Things applications, saw its income and revenue rise in the first quarter of fiscal year 2021-22, thanks in large part to growth in its wireless and sensing products market. Semtech saw revenue rise 28% year-over-year to $170.4 million, the company said when it released its Read More →
Amgen reaches billion-dollar licensing deal with Japanese firm
Amgen announced an agreement June 1 with Kyowa Kirin, a Japanese pharmaceutical company, to jointly develop and commercialize a human monoclonal antibody that Kyowa Kirin is developing to treat atopic dermatitis and other autoimmune diseases. The deal could be worth $1.25 billion or more. Amgen will led the development, manufacturing and commercialization for the treatment, Read More →
Opinion: Remembering David Swensen, a giant in the investment world
By David Kreinces In early May, David Swensen, Yale’s legendary endowment chief, died of cancer at age 67. Swensen was famous on Wall Street for successfully diversifying Yale’s portfolio in a wide range of alternative investments, and he was also loved for his 2005 book on exchange-traded funds (ETFs). The book, “Unconventional Success,” showed Swensen’s Read More →
Amgen gets FDA approval for potential billion-dollar drug
Thousand Oaks-based Amgen won approval from the U.S. Food and Drug Administration on May 28 for its latest oral drug treatment, Lumakras, potentially adding another huge market for one of the largest biotech firms in the world. According to the Wall Street Journal, Amgen will charge $17,900 a month for the drug and analyst think Read More →
QAD stock rises after earnings beat
QAD, a Santa Barbara-based cloud software company for the manufacturing industry, beat analysts’ expectations with its earning for the first quarter of its 2021-22 fiscal year on May 26. QAD’s net income for the quarter was $1.8 million, or 7 cents per share, compared to a loss of $410,000 in the same quarter a year Read More →
Deckers shares rise on news of record sales and earnings
Shares of Deckers Brands, the Goleta-based parent company of Ugg and other footwear brands, jumped 7% on May 20 following the announcement of its fourth quarter and full-year 2020 financial results, which included big jumps in both revenue and net income. Net sales increased 19.4% from 2019 to 2020, to $2.5 billion, the most in Read More →
